Clinical Trials Browser

OTHER × Lomustine × Clear all

NCT05095376 2026-05-19

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Phase 3 Active not recruiting

Glioblastoma, Gliosarcoma

NCT03970447 2026-05-15

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT05331521 2026-02-03

ImproveCodel

Phase 3 Recruiting

Oligodendroglioma

NCT00887146 2026-01-22

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Phase 3 Active not recruiting

Astrocytoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT04049669 2026-01-08

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Phase 2 Active not recruiting

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT07145112 2025-10-09

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

Phase 1 Recruiting

Glioblastoma

NCT04863950 2025-08-27

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT06177964 2025-08-17

Lerapolturev (PVSRIPO) in GBM

Phase 2 Recruiting

Glioblastoma, Glioma

NCT06283927 2024-02-28

RECSUR

Astrocytoma, Glioblastoma

NCT03425292 2023-11-08

A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer

Phase 1 Completed

Newly Diagnosed High Grade Glioma

NCT05410301 2023-04-21

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Phase NA Withdrawn

Glioblastoma

NCT05017610 2022-12-02

Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

Phase EARLY_PHASE1 Withdrawn

Glioblastoma, Gliosarcoma

NCT02926222 2022-09-09

REGOMA

Phase 2 Completed

Glioblastoma

NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Phase 4 Recruiting

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03022578 2022-08-10

Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

Phase 2 Terminated

7 enrolled 9 charts

Astrocytoma, Glioblastoma

NCT02843230 2022-04-08

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Brain Neoplasms, Glioblastoma

NCT02212574 2021-11-05

Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

Phase EARLY_PHASE1 Terminated

6 enrolled 6 charts

Medulloblastoma

NCT02076152 2021-07-30

FMISO PET Study of Glioblastoma

Phase NA Completed

11 enrolled 11 charts

Glioblastoma

NCT03025893 2021-04-19

STELLAR

Phase 2/3 Unknown

Brain Neoplasms, Glioblastoma

NCT02678975 2021-03-18

Disulfiram in Recurrent Glioblastoma

Phase 2/3 Completed

Glioblastoma, Glioma

NCT00058370 2020-05-11

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

Phase NA Completed

6 enrolled 8 charts

Medulloblastoma, Central Nervous System Neoplasms

NCT01614132 2020-03-31

NOA-07

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

NCT01067469 2020-03-17

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Completed

83 enrolled 15 charts

Brain Neoplasms, Glioblastoma

NCT00031590 2019-04-25

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Phase 2 Terminated

30 enrolled 5 charts

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

NCT01562197 2019-01-24

AxiGII

Phase 2 Completed

Glioblastoma, Recurrence

NCT00527657 2018-11-14

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Phase 1 Completed

CNSDermatologic

Brain Neoplasms, Melanoma

NCT01149109 2017-06-14

CeTeG

Phase 3 Completed

Glioblastoma

NCT00074191 2017-04-21

Protocol-A

Phase 2 Completed

Lymphoma, Intraocular Lymphoma

NCT01989052 2016-08-04

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Phase 1 Terminated

Glioma, Lymphoma, Follicular

NCT00002806 2016-07-13

Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma

Phase 2 Completed

Astrocytoma, Central Nervous System Neoplasms

NCT02333513 2015-04-09

A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

Phase NA Unknown

Glioma

NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase 1 Completed

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT00590837 2014-04-02

LAM-SA 2007

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00303810 2014-01-28

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

Phase NA Completed

Central Nervous System Neoplasms

NCT00003101 2013-06-25

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Phase 2 Completed

Oligodendroglioma, Central Nervous System Neoplasms

NCT00293280 2013-05-06

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00072345 2013-01-18

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Phase 2 Unknown

Glioblastoma, Recurrence

NCT00003929 2012-03-20

Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Withdrawn

Lymphoma

NCT00504660 2012-01-11

6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

Phase 2 Completed

75 enrolled 8 charts

Brain Neoplasms, Glioblastoma

NCT00003113 2011-01-17

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003114 2010-06-11

Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease

Phase 2 Completed

Lymphoma, Lymphoma, AIDS-Related

NCT00049439 2010-06-11

Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma

NCT00989352 2009-10-05

PRIMAIN

Phase 2 Unknown

Lymphoma

NCT00480064 2007-05-30

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Phase 3 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute